Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptors (ER) and progesterone receptors (PR) expression, and the absence of the overexpression of the human epidermal growth factor receptor 2 (HER-2). Here, ESR1 is linked to triple-negative breast carcinoma.